BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder

  November 7, 2025

   · 

  3 min read
• Press Releases

  Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study

  November 7, 2025

   · 

  9 min read
• Press Releases

  Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

  November 7, 2025

   · 

  9 min read
• Press Releases

  MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

  November 7, 2025

   · 

  12 min read
• Press Releases

  LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates

  November 7, 2025

   · 

  12 min read
• Press Releases

  RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

  November 7, 2025

   · 

  9 min read
• Press Releases

  PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results

  November 7, 2025

   · 

  5 min read
• Press Releases

  Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025

  November 7, 2025

   · 

  3 min read
• Press Releases

  Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program

  November 7, 2025

   · 

  3 min read
• Press Releases

  Dentsply Sirona Reports Third Quarter 2025 Results

  November 7, 2025

   · 

  26 min read